Suppr超能文献

复方草药药物包封生物合成壳聚糖纳米生物聚合物对糖尿病及其并发症的更高效率。

Greater efficiency of polyherbal drug encapsulated biosynthesized chitosan nano-biopolymer on diabetes and its complications.

机构信息

PG and Research Dept. of Zoology, Nehru Memorial College (Autonomous), Puthanampatti, Tiruchirappalli, Tamilnadu, India.

PG and Research Dept. of Zoology, Holy Cross College (Autonomous), Tiruchirappalli, Tamilnadu, India.

出版信息

Int J Biol Macromol. 2023 Jun 15;240:124445. doi: 10.1016/j.ijbiomac.2023.124445. Epub 2023 Apr 14.

Abstract

Diabetes is a highly complex disease that has an adverse impact on the lives of individuals, and the current medicines used to manage diabetes have obvious side effects. Medicinal plants, on the other hand, may serve as an alternate source of anti-diabetic drugs. A polyherbal combination has a higher and more extensive therapeutic potential than a single herb. Yet, due to deterioration during the absorption process, the usage of this drug still yields inadequate results. Encapsulation of polyherbal drug with chitosan nanoparticles is one of the key ways to solve this problem due to its biocombatibilty, slow and targeted drug delivery characteristics. In the present study, the chitosan was derived from prawn shell and the chitosan nanoparticles had been prepared by ionic-gelation method. The anti-diabetic polyherbal drug (Andrographis paniculata, Andrographis alata, Adhatoda zeylanica, Gymnema sylvestre, Syzygium cumini, and Justicia glabra) was encapsulated with a bio-derived chitosan biopolymer. The drug loading efficiency was about 85 %. The chemical and physical properties of the chitosan and drug-loaded chitosan nanoparticles had been analyzed by FT-IR absorption, XRD, SEM, TEM and EDAX analysis. The antidiabetic efficiency, hepatoprotective activity and antihyperlipedimic activity of the chitosan nanoparticles, polyherbal drug and polyherbal drug encapsulated with chitosan nanoparticles were assessed in a group of rats. The polyherbal drug reduced the serum glucose level from 306.4 mg/dL to 134.47 mg/dL, while the polyherbal drug encapsulated with chitosan nanoparticles reduced to 127.017 mg/dL. This was very close to the serum glucose level of non-diabetic rat (124.65 mg/dL). Further, it considerably increased the insulin level close to that of non-diabetic rat. Thus, the polyherbal drug encapsulated with chitosan nanoparticles showed superior efficiency in antidiabetic and also diabetic complications.

摘要

糖尿病是一种高度复杂的疾病,会对个人生活产生不利影响,而目前用于治疗糖尿病的药物有明显的副作用。另一方面,药用植物可能是抗糖尿病药物的替代来源。与单一草药相比,复方草药具有更高和更广泛的治疗潜力。然而,由于在吸收过程中发生恶化,这种药物的使用仍然产生不足的结果。由于壳聚糖的生物相容性、缓慢和靶向药物输送特性,用壳聚糖纳米粒子包裹复方草药药物是解决这个问题的关键方法之一。在本研究中,壳聚糖是从虾壳中提取的,壳聚糖纳米粒子是通过离子凝胶法制备的。抗糖尿病复方草药(穿心莲、印度獐牙菜、吐根、匙羹藤、罗望子和辣木叶)用生物衍生的壳聚糖生物聚合物包裹。药物负载效率约为 85%。通过傅里叶变换红外吸收、X 射线衍射、扫描电子显微镜、透射电子显微镜和能谱分析对壳聚糖和载药壳聚糖纳米粒子的化学和物理性质进行了分析。在一组大鼠中评估了壳聚糖纳米粒子、复方草药、载药壳聚糖纳米粒子的抗糖尿病效率、肝保护活性和抗高脂血症活性。复方草药将血清葡萄糖水平从 306.4mg/dL 降低到 134.47mg/dL,而载药壳聚糖纳米粒子则降低到 127.017mg/dL。这非常接近非糖尿病大鼠的血清葡萄糖水平(124.65mg/dL)。此外,它还显著提高了胰岛素水平,接近非糖尿病大鼠的水平。因此,载药壳聚糖纳米粒子在抗糖尿病和糖尿病并发症方面表现出更高的效率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验